Nicole Sweeny
Corporate Officer/Principal chez KALVISTA PHARMACEUTICALS, INC.
Profil
Nicole Sweeny is currently the Chief Commercial Officer at KalVista Pharmaceuticals, Inc. Prior to her current position, she worked as the Vice President of US Marketing at Shire Plc from 2016 to 2019, Vice President-Franchise Head at Takeda Pharmaceuticals U.S.A., Inc. from 2019 to 2020, and Chief Commercial Officer at Praxis Precision Medicines, Inc. from 2020 to 2023.
She received her undergraduate degree from Boston College.
Postes actifs de Nicole Sweeny
| Sociétés | Poste | Début |
|---|---|---|
| KALVISTA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 25/07/2023 |
Anciens postes connus de Nicole Sweeny
| Sociétés | Poste | Fin |
|---|---|---|
| PRAXIS PRECISION MEDICINES, INC. | Corporate Officer/Principal | 31/03/2023 |
Takeda Pharmaceuticals U.S.A., Inc.
 Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Corporate Officer/Principal | 01/07/2020 |
| SHIRE | Corporate Officer/Principal | 01/01/2019 |
Formation de Nicole Sweeny
| Boston College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| PRAXIS PRECISION MEDICINES, INC. | Health Technology |
| KALVISTA PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Health Technology |
